Brief: Hemant Surgical Industries Buys 66.66% Stake In Lifesenz Cancer Research Labs For 199.8 Million Rupees
09/06/2026 10:38
BRIEF-Hemant Surgical Industries Buys 66.66% Stake In Lifesenz Cancer Research Labs For 199.8 Million Rupees June 9 (Reuters) - Hemant Surgical Industries Ltd HEMT.BO:
HEMANT SURGICAL INDUSTRIES - BUYS 66.66% STAKE IN LIFESENZ CANCER RESEARCH LABS FOR 199.8 MILLION RUPEES
Source text: ID:nBSETdlmk
Further company coverage: HEMT.BO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Hemant Surgical Industries
See all newsBrief: Hemant Surgical Industries Buys 66.66% Stake In Lifesenz Cancer Research Labs For 199.8 Million Rupees
Brief: Hemant Surgical Industries Enters Agreement To Buy 66.66% Stake Of Lifesenz Cancer Research Labs
Brief: Hemant Surgical Industries Ltd Enters C-Arm Development And Supply Agreement With GBT Korea Co Ltd.
Brief: Hemant Surgical Industries Gets Supply Contract Valued At 2.64 Billion Rupees
Brief: Hemant Surgical Industries Says Fire Incident Occurred In Factory At F2 Of Dharam Square